ArticleBMC infectious diseases2024

Immune response to the recombinant herpes zoster vaccine in people living with HIV over 50 years of age compared to non-HIV age-/gender-matched controls (SHINGR'HIV): a multicenter, international, non-randomized clinical trial study protocol.

Maxime Hentzien et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.